Arenas, A.M.; Cuadros, M.; Andrades, A.; García, D.J.; Coira, I.F.; Rodríguez, M.I.; Baliñas-Gavira, C.; Peinado, P.; Álvarez-Pérez, J.C.; Medina, P.P.
LncRNA DLG2-AS1 as a Novel Biomarker in Lung Adenocarcinoma. Cancers 2020, 12, 2080.
https://doi.org/10.3390/cancers12082080
AMA Style
Arenas AM, Cuadros M, Andrades A, García DJ, Coira IF, Rodríguez MI, Baliñas-Gavira C, Peinado P, Álvarez-Pérez JC, Medina PP.
LncRNA DLG2-AS1 as a Novel Biomarker in Lung Adenocarcinoma. Cancers. 2020; 12(8):2080.
https://doi.org/10.3390/cancers12082080
Chicago/Turabian Style
Arenas, Alberto M., Marta Cuadros, Alvaro Andrades, Daniel J. García, Isabel F. Coira, María Isabel Rodríguez, Carlos Baliñas-Gavira, Paola Peinado, Juan Carlos Álvarez-Pérez, and Pedro P. Medina.
2020. "LncRNA DLG2-AS1 as a Novel Biomarker in Lung Adenocarcinoma" Cancers 12, no. 8: 2080.
https://doi.org/10.3390/cancers12082080
APA Style
Arenas, A. M., Cuadros, M., Andrades, A., García, D. J., Coira, I. F., Rodríguez, M. I., Baliñas-Gavira, C., Peinado, P., Álvarez-Pérez, J. C., & Medina, P. P.
(2020). LncRNA DLG2-AS1 as a Novel Biomarker in Lung Adenocarcinoma. Cancers, 12(8), 2080.
https://doi.org/10.3390/cancers12082080